HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era
Maria João Baptista(Josep Carreras Leukaemia Research Institute), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Mireia Morgades(Josep Carreras Leukaemia Research Institute), Eva González‐Barca(Institut Català d'Oncologia), Eugènia Abella(Hospital Del Mar), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Pilar Miralles(Hospital General Universitario Gregorio Marañón), Miriam Moreno(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), Olga García(Universitat Autònoma de Barcelona), Armando López‐Guillermo(Barcelona Supercomputing Center)
Cited by 50
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k